Article Details

Digital therapeutics, medication adherence, clinical trials were key pharma interests in Q2

Retrieved on: 2018-07-06 02:33:45

Tags for this article:

Click the tags to see associated articles and topics

Digital therapeutics, medication adherence, clinical trials were key pharma interests in Q2. View article details on hiswai:

Excerpt

<div>Also present at the event was Roche, which recently acquired oncology tech company <b>Flatiron Health</b>. In May, Flatiron and Bristol-Myers Squibb ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo